Eyebright Medical Continues to Employ Its Internationalization Strategy: Signed Memorandum with Invest Hong Kong and Spotlight at ESCRS 2024
HONG KONG, Sept. 24, 2024 /PRNewswire/ -- Eyebright Medical Technology (Beijing ) Co., Ltd. ("Eyebright Medical", the "Company", Stock Code: 688050.SH, together with its subsidiaries collectively known as the "Group") is pleased to announce the recently development of its internationalization stra...
2024-09-24 20:00
1709
Eyebright Medical Announces Strong First Half 2024 Results, with Revenue Surpassing 68% Growth and Net Profit Rising by Nearly 30%
HONG KONG, Aug. 22, 2024 /PRNewswire/ -- Eyebright Medical Technology (Beijing) Ltd ('Eyebright Medical'; the 'Company'; SH Stock Code: 688050), the first domestic manufacturer of high-end refractive intraocular lenses inChina, today announced its financial results for the first half of 2024. Th...
2024-08-22 00:00
2058
